Barbara A. Kosciolek
University of Rochester
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Barbara A. Kosciolek.
Genes, Chromosomes and Cancer | 1998
Barbara A. Kosciolek; Peter T. Rowley
Research on both cancer and aging has focused attention on the regulation of telomerase, the enzyme that synthesizes the ends of chromosomal DNA. To analyze the relative importance of genetic vs. environmental factors in determining telomerase inducibility, we have compared telomerase activity in phytohemagglutinin‐stimulated peripheral blood lymphocytes from monozygotic and dizygotic twin pairs. The heritability calculated was 0.814, indicating that lymphocyte inducible telomerase activity is determined principally by genetic rather than by environmental factors. Genes Chromosomes Cancer 21:124–130, 1998.
Leukemia Research | 1999
Barbara A. Kosciolek; Peter T. Rowley
Since telomerase activity is present in most malignant cells, but absent in most normal cells, its induction in normal cells warrants scrutiny. Therefore we have analyzed the inducibility of telomere-related components in normal lymphocytes during their activation. Telomerase activity increased over 400-fold, telomerase reverse transcriptase (hTERT) mRNA 52 x , telomerase RNA 32 x , TTAGGG repeat binding factor 1 mRNA 19 x , TTAGGG repeat binding factor 2 mRNA 20 x , and telomerase-associated protein mRNA 17 x . The peak value for each was reached at about 72 h. However hTERT rose fastest and synchronously with telomerase activity. Thus in normal human lymphocytes (1) the syntheses of all cloned telomerase-related components are coordinately regulated and (2) hTERT may have a priming role.
Annals of the New York Academy of Sciences | 1986
Peter T. Rowley; Barbara A. Kosciolek; Judith L. Bader
To investigate the role of oncogenes in malignancies characteristic of neurofibromatosis, oncogene transcripts were quantitated in a neurofibrosarcoma and in control tissue from a patient with hereditary neurofibromatosis. Sis and N-ras were moderately hyperexpressed, raf, Blym, and erbA were slightly hyperexpressed, and abl, erbB, fes/fps, fgr, fos, mos, myb, myc, N-myc, rasHarvey, rasKirsten, ros, src, and yes were not hyperexpressed in the tumor compared to the control tissue. Although additional tumors will be assayed before conclusions are possible, it may be significant that the two oncogenes most hyperexpressed are prior suspects for a pathogenetic role in tumors of the nervous system.
Genes, Chromosomes and Cancer | 1989
Gary R. Skuse; Barbara A. Kosciolek; Peter T. Rowley
Molecular Cancer Therapeutics | 2003
Barbara A. Kosciolek; Kriton Kalantidis; Martin Tabler; Peter T. Rowley
American Journal of Human Genetics | 1991
Gary R. Skuse; Barbara A. Kosciolek; Peter T. Rowley
Leukemia Research | 1996
Peter T. Rowley; Peter C. Keng; Barbara A. Kosciolek
American Journal of Hematology | 1979
Ashabala Veer; Barbara A. Kosciolek; Arthur W. Bauman; Peter T. Rowley
Leukemia Research | 1994
Margaret Thomas; Barbara A. Kosciolek; Nancy Wang; Peter T. Rowley
Proceedings of the National Academy of Sciences of the United States of America | 1979
Peter T. Rowley; Betsy M. Ohlsson-Wilhelm; Barbara A. Farley; Barbara A. Kosciolek